RESUMEN
BACKGROUND: In 2010-2017, meningococcal serogroup A conjugate vaccine (MACV) was introduced in 21 African meningitis belt countries. Neisseria meningitidis A epidemics have been eliminated here; however, non-A serogroup epidemics continue. METHODS: We reviewed epidemiological and laboratory World Health Organization data after MACV introduction in 20 countries. Information from the International Coordinating Group documented reactive vaccination. RESULTS: In 2011-2017, 17 outbreaks were reported (31 786 suspected cases from 8 countries, 1-6 outbreaks/year). Outbreaks were of 18-14 542 cases in 113 districts (median 3 districts/outbreak). The most affected countries were Nigeria (17 375 cases) and Niger (9343 cases). Cumulative average attack rates per outbreak were 37-203 cases/100 000 population (median 112). Serogroup C accounted for 11 outbreaks and W for 6. The median proportion of laboratory confirmed cases was 20%. Reactive vaccination was conducted during 14 outbreaks (5.7 million people vaccinated, median response time 36 days). CONCLUSION: Outbreaks due to non-A serogroup meningococci continue to be a significant burden in this region. Until an affordable multivalent conjugate vaccine becomes available, the need for timely reactive vaccination and an emergency vaccine stockpile remains high. Countries must continue to strengthen detection, confirmation, and timeliness of outbreak control measures.
Asunto(s)
Brotes de Enfermedades , Meningitis Meningocócica/epidemiología , Meningitis Meningocócica/microbiología , Neisseria meningitidis Serogrupo A , África del Sur del Sahara/epidemiología , Historia del Siglo XXI , Humanos , Incidencia , Meningitis Meningocócica/historia , Meningitis Meningocócica/prevención & control , Vacunas Meningococicas/inmunología , Neisseria meningitidis Serogrupo A/clasificación , Neisseria meningitidis Serogrupo A/genética , Neisseria meningitidis Serogrupo A/inmunología , Vigilancia en Salud Pública , Estaciones del Año , Vacunación , Vacunas Conjugadas/inmunologíaRESUMEN
BACKGROUND: A novel meningococcal serogroup A conjugate vaccine (MACV [MenAfriVac]) was developed as part of efforts to prevent frequent meningitis outbreaks in the African meningitis belt. The MACV was first used widely and with great success, beginning in December 2010, during initial deployment in Burkina Faso, Mali, and Niger. Since then, MACV rollout has continued in other countries in the meningitis belt through mass preventive campaigns and, more recently, introduction into routine childhood immunization programs associated with extended catch-up vaccinations. METHODS: We reviewed country reports on MACV campaigns and routine immunization data reported to the World Health Organization (WHO) Regional Office for Africa from 2010 to 2018, as well as country plans for MACV introduction into routine immunization programs. RESULTS: By the end of 2018, 304 894 726 persons in 22 of 26 meningitis belt countries had received MACV through mass preventive campaigns targeting individuals aged 1-29 years. Eight of these countries have introduced MACV into their national routine immunization programs, including 7 with catch-up vaccinations for birth cohorts born after the initial rollout. The Central African Republic introduced MACV into its routine immunization program immediately after the mass 1- to 29-year-old vaccinations in 2017 so no catch-up was needed. CONCLUSIONS: From 2010 to 2018, successful rollout of MACV has been recorded in 22 countries through mass preventive campaigns followed by introduction into routine immunization programs in 8 of these countries. Efforts continue to complete MACV introduction in the remaining meningitis belt countries to ensure long-term herd protection.
Asunto(s)
Meningitis Meningocócica/prevención & control , Vacunas Meningococicas/inmunología , Neisseria meningitidis Serogrupo A/inmunología , Vacunas Conjugadas/inmunología , África/epidemiología , Brotes de Enfermedades , Femenino , Geografía Médica , Humanos , Programas de Inmunización , Inmunización Secundaria , Masculino , Vacunas Meningococicas/administración & dosificación , Neisseria meningitidis Serogrupo A/clasificación , Vigilancia en Salud Pública , Vacunación , Vacunas Conjugadas/administración & dosificaciónRESUMEN
OBJECTIVES: The bacterial pathogen Neisseria meningitidis is able to escape the currently available capsule-based vaccines by undergoing capsule switching. In this study, we investigated whether capsule switching has occurred in a recently emerged sequence type (ST) 7 serogroup X isolate in China, for which currently no vaccine is available. METHODS: To identify capsule switching breakpoints, the capsule locus and flanking regions of the ST-7 serogroup X isolate and three endemic ST-7 serogroup A isolates were sequenced and compared. To obtain further insight into capsule switching frequency and length of DNA fragments involved, capsule switching assays were performed using genomic DNA containing combinations of antibiotic selection markers at various locations in the capsule locus and flanking regions. RESULTS: Sequence analyses showed that capsule switching has occurred and involved a 8450 bp serogroup X DNA fragment spanning the region from galE to ctrC. Capsule switching assays indicate that capsule switching occurs at a frequency of 6.3 × 10-6 per bacterium per µg of DNA and predominantly involved DNA fragments of about 8.1-9.6 kb in length. CONCLUSIONS: Our results show that capsule switching in N. meningitidis occurs at high frequency and involves recombination in the flanking regions of the capsule biosynthesis genes.
Asunto(s)
Cápsulas Bacterianas/genética , Cápsulas Bacterianas/inmunología , Infecciones Meningocócicas/inmunología , Vacunas Meningococicas/genética , Vacunas Meningococicas/inmunología , Neisseria meningitidis Serogrupo A/genética , China , ADN Bacteriano , Humanos , Infecciones Meningocócicas/microbiología , Neisseria meningitidis Serogrupo A/clasificación , Neisseria meningitidis Serogrupo A/inmunología , Recombinación Genética , Análisis de Secuencia de ADN , SerogrupoRESUMEN
In the African "meningitis belt," outbreaks of meningococcal meningitis occur in cycles, representing a model for the role of host-pathogen interactions in epidemic processes. The periodicity of the epidemics is not well understood, nor is it currently possible to predict them. In our longitudinal colonization and disease surveys, we have observed waves of clonal replacement with the same serogroup, suggesting that immunity to noncapsular antigens plays a significant role in natural herd immunity. Here, through comparative genomic analysis of 100 meningococcal isolates, we provide a high-resolution view of the evolutionary changes that occurred during clonal replacement of a hypervirulent meningococcal clone (ST-7) by a descendant clone (ST-2859). We show that the majority of genetic changes are due to homologous recombination of laterally acquired DNA, with more than 20% of these events involving acquisition of DNA from other species. Signals of adaptation to evade herd immunity were indicated by genomic hot spots of recombination. Most striking is the high frequency of changes involving the pgl locus, which determines the glycosylation patterns of major protein antigens. High-frequency changes were also observed for genes involved in the regulation of pilus expression and the synthesis of Maf3 adhesins, highlighting the importance of these surface features in host-pathogen interaction and immune evasion. Importance: While established meningococcal capsule polysaccharide vaccines are protective through the induction of anticapsular antibodies, findings of our longitudinal studies in the African meningitis belt have indicated that immunity to noncapsular antigens plays a significant role in natural herd immunity. Our results show that meningococci evade herd immunity through the rapid homologous replacement of just a few key genomic loci that affect noncapsular cell surface components. Identification of recombination hot spots thus represents an eminent approach to gain insight into targets of protective natural immune responses. Moreover, our results highlight the role of the dynamics of the protein glycosylation repertoire in immune evasion by Neisseria meningitidis. These results have major implications for the design of next-generation protein-based subunit vaccines.
Asunto(s)
Brotes de Enfermedades , Genoma Bacteriano , Evasión Inmune , Meningitis Meningocócica/epidemiología , Neisseria meningitidis Serogrupo A/clasificación , Neisseria meningitidis Serogrupo A/genética , África/epidemiología , Antígenos Bacterianos/genética , Transferencia de Gen Horizontal , Genotipo , Recombinación Homóloga , Humanos , Neisseria meningitidis Serogrupo A/inmunología , Neisseria meningitidis Serogrupo A/aislamiento & purificación , Filogenia , Análisis de Secuencia de ADN , Homología de SecuenciaRESUMEN
In particular in the 'meningitis belt' of sub-Saharan Africa, epidemic meningococcal meningitis is a severe public health problem. In the past decades, serogroup A lineages have been the dominant etiologic agents, but also other serogroups have caused outbreaks. A comprehensive vaccine based on subcapsular outer membrane proteins (OMPs) is not available. Here, we have investigated whether meningococcal populations overcome herd immunity by changing antigenic properties of their OMPs. Meningococcal isolates were collected in the context of longitudinal studies in Ghana between 2002 and 2008 and in Burkina Faso between 2006 and 2007. Serogroup A strains isolated during two clonal waves of colonization and disease showed no diversification in the genes encoding their PorA, PorB, and FetA proteins. However, we detected occasional allelic exchange of opa genes, as well as wide variation in the number of intragenic tandem repeats, showing that phase variation of Opa protein expression is a frequent event. Altogether we observed a remarkable antigenic stability of the PorA, PorB and FetA proteins over years. Our results indicate that while herd immunity may be responsible for the disappearance of meningococcal clones over time, it is not a strong driving force for antigenic diversification of the major OMPs analyzed here.
Asunto(s)
Variación Antigénica , Proteínas de la Membrana Bacteriana Externa/genética , Meningitis Meningocócica/epidemiología , Meningitis Meningocócica/microbiología , Neisseria meningitidis Serogrupo A/clasificación , Neisseria meningitidis Serogrupo A/genética , Proteínas de la Membrana Bacteriana Externa/inmunología , Burkina Faso/epidemiología , Análisis Mutacional de ADN , ADN Bacteriano/química , ADN Bacteriano/genética , ADN Bacteriano/aislamiento & purificación , Ghana/epidemiología , Humanos , Estudios Longitudinales , Epidemiología Molecular , Neisseria meningitidis Serogrupo A/aislamiento & purificación , Análisis de Secuencia de ADNRESUMEN
The lipooligosaccharide (LOS) of immunotype L11 is unique within serogroup A meningococci. In order to resolve its molecular structure, we conducted LOS genotyping by PCR analysis of genes responsible for alpha-chain sugar addition (lgtA, -B, -C, -E, -H, and -F) and inner core substituents (lgtG, lpt-3, and lpt-6). For this study, we selected seven strains belonging to subgroup III, a major clonal complex responsible for meningococcal meningitis epidemics in Africa. In addition, we sequenced the homopolymeric tract regions of three phase-variable genes (lgtA, lgtG, and lot-3) to predict gene functionality. The fine structure of the L11 LOS of each strain was determined using composition and glycosyl linkage analyses, NMR, and mass spectrometry. The masses of the dephosphorylated oligosaccharides were consistent with an oligosaccharide composed of two hexoses, one N-acetyl-hexosamine, two heptoses, and one KDO, as proposed previously. The molar composition of LOS showed two glucose residues to be present, in agreement with lgtH sequence prediction. Despite phosphoethanolaminetransferase genes lpt-3 and lpt-6 being present in all seven Neisseria meningitidis strains, phosphoethanolamine (PEtn) was found at both O-3 and O-6 of HepII among the three ST-5 strains, whereas among the four ST-7 strains, only one PEtn was found and located at O-3 of the HepII. The L11 LOS was found to be O-acetylated, as was indicated by the presence of the lot-3 gene being in-frame in all of the seven N. meningitidis strains. To our knowledge, these studies represent the first full genetic and structural characterization of the L11 LOS of N. meningitidis. These investigations also suggest the presence of further regulatory mechanisms affecting LOS structure microheterogeneity in N. meningitidis related to PEtn decoration of the inner core.
Asunto(s)
Lipopolisacáridos/biosíntesis , Lipopolisacáridos/química , Neisseria meningitidis Serogrupo A/genética , Neisseria meningitidis Serogrupo A/metabolismo , Proteínas Bacterianas/genética , Proteínas Bacterianas/metabolismo , Sitios de Unión , Secuencia de Carbohidratos , ADN Bacteriano/química , ADN Bacteriano/genética , Electroforesis en Gel de Poliacrilamida , Cromatografía de Gases y Espectrometría de Masas , Glicosilación , Glicosiltransferasas/genética , Glicosiltransferasas/metabolismo , Humanos , Espectroscopía de Resonancia Magnética , Meningitis Meningocócica/microbiología , Datos de Secuencia Molecular , Estructura Molecular , Monosacáridos/análisis , N-Acetilglucosaminiltransferasas/genética , N-Acetilglucosaminiltransferasas/metabolismo , Neisseria meningitidis Serogrupo A/clasificación , Análisis de Secuencia de ADN , Serotipificación , Especificidad de la Especie , Espectrometría de Masa por Láser de Matriz Asistida de Ionización DesorciónRESUMEN
There is currently no comprehensive meningococcal vaccine, due to difficulties in immunizing against organisms expressing serogroup B capsules. To address this problem, subcapsular antigens, particularly the outer-membrane proteins (OMPs), are being investigated as candidate vaccine components. If immunogenic, however, such antigens are often antigenically variable, and knowledge of the extent and structuring of this diversity is an essential part of vaccine formulation. Factor H-binding protein (fHbp) is one such protein and is included in two vaccines under development. A survey of the diversity of the fHbp gene and the encoded protein in a representative sample of meningococcal isolates confirmed that variability in this protein is structured into two or three major groups, each with a substantial number of alleles that have some association with meningococcal clonal complexes and serogroups. A unified nomenclature scheme was devised to catalogue this diversity. Analysis of recombination and selection on the allele sequences demonstrated that parts of the gene are subject to positive selection, consistent with immune selection on the protein generating antigenic variation, particularly in the C-terminal region of the peptide sequence. The highest levels of selection were observed in regions corresponding to epitopes recognized by previously described bactericidal monoclonal antibodies.
Asunto(s)
Antígenos Bacterianos/genética , Proteínas Bacterianas/genética , Neisseria meningitidis/genética , Alelos , Secuencia de Aminoácidos , Antígenos Bacterianos/química , Antígenos Bacterianos/inmunología , Proteínas Bacterianas/química , Proteínas Bacterianas/inmunología , Secuencia de Bases , Cartilla de ADN/genética , ADN Bacteriano/genética , Genes Bacterianos , Variación Genética , Humanos , Infecciones Meningocócicas/microbiología , Vacunas Meningococicas/genética , Vacunas Meningococicas/inmunología , Modelos Moleculares , Datos de Secuencia Molecular , Neisseria meningitidis/clasificación , Neisseria meningitidis/inmunología , Neisseria meningitidis Serogrupo A/clasificación , Neisseria meningitidis Serogrupo A/genética , Neisseria meningitidis Serogrupo A/inmunología , Neisseria meningitidis Serogrupo B/clasificación , Neisseria meningitidis Serogrupo B/genética , Neisseria meningitidis Serogrupo B/inmunología , Recombinación Genética , Selección Genética , Homología de Secuencia de Aminoácido , SerotipificaciónRESUMEN
During 1999-2006, 156 isolates of Neisseria meningitidis grew from culture of blood or cerebrospinal fluid at International Centre for Diarrhoeal Disease Research, Bangladesh, in Dhaka, Bangladesh. Serogroup A was the most prevalent strain (97.7%); the rest were serogroup B (2.3%). Most cases of invasive meningococcal disease (88.5%) were identified in 2002-2004 and most (87.5%) occurred in children, teenagers, and young adults, which reflected a community-wide increase in meningococcal disease incidence during this period, which was not recognized previously. All isolates were susceptible to penicillin, ampicillin, chloramphenicol, ciprofloxacin, and ceftriaxone. Cotrimoxazole resistance steadily increased from 50% to 100% during 2002-2006. Resistance to azithromycin emerged in 2002 (5%), increased to 31% in 2004, but isolates in 2005-2006 were susceptible. Information from broader hospital settings and population-based data would precisely assess trends and impact to define strategies for optimal prevention and empiric therapy.
Asunto(s)
Bacteriemia/microbiología , Líquido Cefalorraquídeo/microbiología , Infecciones Meningocócicas/epidemiología , Infecciones Meningocócicas/microbiología , Neisseria meningitidis Serogrupo A/aislamiento & purificación , Adolescente , Adulto , Antibacterianos/farmacología , Bacteriemia/epidemiología , Bangladesh/epidemiología , Niño , Preescolar , Farmacorresistencia Bacteriana , Femenino , Humanos , Lactante , Recién Nacido , Masculino , Persona de Mediana Edad , Neisseria meningitidis Serogrupo A/clasificación , Neisseria meningitidis Serogrupo A/efectos de los fármacos , Proyectos Piloto , Estudios Retrospectivos , Serotipificación , Adulto JovenRESUMEN
We analysed cerebrospinal fluid samples from suspected meningitis cases in Nouna Health District, Burkina Faso, during the meningitis seasons of 2004-2006. Serogroup A ST2859 meningococci belonging to the ST5 clonal complex of subgroup III meningococci were the predominant causative agent. ST2859 bacteria were associated with focal outbreaks in the north of the district. While >10% of the population of an outbreak village carried ST2859, the population in the south of the district was predominantly colonised by serogroup Y ST4375 meningococci, which were associated with only sporadic cases of meningitis. Colonisation with the less virulent Y meningococci may interfere with the spread of the ST2859 to the south of the district, but there are concerns that this serogroup A clone may cause a third wave of subgroup III meningococcal disease in the African Meningitis Belt.
Asunto(s)
Brotes de Enfermedades , Meningitis Meningocócica/epidemiología , Neisseria meningitidis Serogrupo A/aislamiento & purificación , Adolescente , Adulto , Distribución por Edad , Técnicas de Tipificación Bacteriana , Burkina Faso/epidemiología , Líquido Cefalorraquídeo/microbiología , Niño , Preescolar , Humanos , Lactante , Recién Nacido , Meningitis Meningocócica/microbiología , Persona de Mediana Edad , Neisseria meningitidis Serogrupo A/clasificación , Estudios ProspectivosRESUMEN
Results of microbiological monitoring for serogroup A Neisseria meningitidis circulated in Moscow from 2002 to 2006 are presented. Using multilocus sequence-typing, molecular and epidemiologic characteristics of 32 cultures isolated from cerebro-spinal fluid of patients with generalized forms of meningococcal infection. Typed isolates belonged to 4 sequence types: CT-3349 (detected in 24 cultures), CT-2 (detected in 5 cultures), CT-75 (detected in 2 cultures), and CT-5803 (detected in 1 culture). All sequence types (except CT-5803) were detected in Moscow in previous years. Using Internet database (http://pubmlst.org/neisseria) they were genetically characterized and compared with data on serogroup A meningococci circulated in Moscow before 2002., meningococci belonging to epidemically dangerous genetic subgroup III were not detected between characterized strains. Typed isolates were distributed between subgroups VI and X, which are typical for the area under surveillance. Genetic changes in Moscow population of Neisseria meningitidis serogroup A, which manifested by shift of dominating genetic subgroup after 2002-2003, were analyzed.
Asunto(s)
Infecciones Meningocócicas/microbiología , Neisseria meningitidis Serogrupo A/genética , Neisseria meningitidis/clasificación , Neisseria meningitidis/genética , Técnicas de Tipificación Bacteriana , Líquido Cefalorraquídeo/microbiología , ADN Bacteriano/genética , Monitoreo del Ambiente , Humanos , Moscú , Neisseria meningitidis Serogrupo A/clasificación , Filogenia , Análisis de Secuencia de ADN , SerotipificaciónRESUMEN
Analysis of meningococcal strains recovered from outbreaks and epidemics in the African meningitis belt, using molecular methods, has demonstrated for nearly 20 years the dominance among serogroup A organisms of a single clone complex, the sequence type 5 (ST-5) complex. However, a shift was observed since the mid-1990s when ST-5 gradually was replaced by ST-7 in all countries of the region. Since 2001, outbreaks caused by serogroup W135 strains belonging to the ST-11 complex became an additional problem. Monitoring of the clones responsible for meningococcal disease provides important insights on the biology and epidemiology of this most serious pathogen.
Asunto(s)
Brotes de Enfermedades , Meningitis Meningocócica/epidemiología , África/epidemiología , Humanos , Neisseria meningitidis Serogrupo A/clasificación , Neisseria meningitidis Serogrupo A/genética , Neisseria meningitidis Serogrupo A/aislamiento & purificación , Neisseria meningitidis Serogrupo W-135/clasificación , Neisseria meningitidis Serogrupo W-135/aislamiento & purificaciónRESUMEN
Although Neisseria meningitidis is a highly variable organism, most invasive disease is caused by a minority of genotypes. Hypervirulent lineages have been identified and their pandemic spread has been traced. During a longitudinal meningococcal colonization study in a district of northern Ghana clonal waves of carriage and disease were observed. Genetic diversification of genoclouds was analysed by pulsed field gel electrophoretic (PFGE) analysis of isolates from healthy carriers and from meningitis patients. Even during the limited time of persistence in the district, microevolution of the dominating genoclouds took place. Population genomic analyses are required to understand the genetic basis for the emergence of new lineages with epidemic potential, which is of crucial importance for the development of long-term global vaccination strategies against meningococcal disease.
Asunto(s)
Variación Genética , Meningitis Meningocócica/epidemiología , Neisseria meningitidis/genética , ADN Bacteriano/análisis , ADN Bacteriano/genética , Electroforesis en Gel de Campo Pulsado , Geografía , Ghana/epidemiología , Humanos , Meningitis Meningocócica/inmunología , Neisseria meningitidis/clasificación , Neisseria meningitidis/patogenicidad , Neisseria meningitidis Serogrupo A/clasificación , Neisseria meningitidis Serogrupo A/genética , Neisseria meningitidis Serogrupo A/patogenicidad , Neisseria meningitidis Serogrupo W-135/clasificación , Neisseria meningitidis Serogrupo W-135/genética , Neisseria meningitidis Serogrupo W-135/patogenicidad , Serotipificación , Factores de Tiempo , VirulenciaRESUMEN
Decreased susceptibility of Neisseria meningitidis isolates to ciprofloxacin emerged from an outbreak in Delhi, India. Results of antimicrobial susceptibility testing of the meningococcal isolates to ciprofloxacin and further sequencing of DNA gyrase A quinolone-resistance-determining region confirmed the emergence of ciprofloxacin resistance in the outbreak.
Asunto(s)
Brotes de Enfermedades , Farmacorresistencia Bacteriana Múltiple , Infecciones Meningocócicas/epidemiología , Neisseria meningitidis Serogrupo A/efectos de los fármacos , Ciprofloxacina/farmacología , Humanos , India/epidemiología , Infecciones Meningocócicas/tratamiento farmacológico , Pruebas de Sensibilidad Microbiana , Neisseria meningitidis Serogrupo A/clasificación , Neisseria meningitidis Serogrupo A/genética , SerotipificaciónAsunto(s)
Centros Médicos Académicos , Bacteriemia/epidemiología , Sangre/microbiología , Meningitis Meningocócica/epidemiología , Neisseria meningitidis/aislamiento & purificación , Adolescente , Adulto , Anciano , Bacteriemia/microbiología , Niño , Preescolar , Medios de Cultivo , Femenino , Humanos , India/epidemiología , Masculino , Meningitis Meningocócica/microbiología , Persona de Mediana Edad , Neisseria meningitidis/clasificación , Neisseria meningitidis/genética , Neisseria meningitidis Serogrupo A/clasificación , Neisseria meningitidis Serogrupo A/genética , Neisseria meningitidis Serogrupo A/aislamiento & purificaciónRESUMEN
Although invasive meningococcal disease caused by serogroup A is not prevalent in developed countries, a considerable number of cases were recently recorded in Greece. In this study, serogroup A meningococcal disease was compared prospectively with meningococcal disease caused by other serogroups, using similar settings of testing and management during a 5-year period between 1999 and 2003. The Neisseria meningitidis serogroup was determined in 262 cases. Serogroup B predominated, accounting for 158 (60%) of the cases. Serogroup A was second most frequent (19%), followed by serogroups W135 (11%), C (8%), and Y (2%). No cases due to serogroup C were recorded during the last year of the study. Patients with serogroup A disease were older and had a milder course compared to patients infected with serogroups B or C. Toxic appearance, purpura, thrombocytopenia, abnormal coagulation tests, and the need for admission to the intensive care unit, fluid resuscitation, inotropic drugs, and mechanical ventilation were less common. Although morbidity and mortality were lower in these patients, the differences were not significant. Serogroup B is predominant in our area, and the introduction of an effective vaccine against it is a priority. Serogroup A has emerged as the second most common serogroup, but the illness associated with it is milder.
Asunto(s)
Infecciones Meningocócicas/microbiología , Neisseria meningitidis Serogrupo A , Adolescente , Niño , Preescolar , Femenino , Grecia/epidemiología , Humanos , Lactante , Masculino , Infecciones Meningocócicas/diagnóstico , Infecciones Meningocócicas/epidemiología , Neisseria meningitidis Serogrupo A/clasificación , Neisseria meningitidis Serogrupo A/aislamiento & purificación , Neisseria meningitidis Serogrupo B/clasificación , Neisseria meningitidis Serogrupo B/aislamiento & purificación , Neisseria meningitidis Serogrupo C/clasificación , Neisseria meningitidis Serogrupo C/aislamiento & purificación , Neisseria meningitidis Serogrupo W-135/clasificación , Neisseria meningitidis Serogrupo W-135/aislamiento & purificación , Resultado del TratamientoRESUMEN
The objectives of this study were to collect and characterize epidemic meningococcal isolates from Ethiopia from 2002 to 2003 and to compare them to 21 strains recovered during the previous large epidemic of 1988 to 1989. Ninety-five patients in all age groups with clinical signs of meningitis and a turbid cerebrospinal fluid (CSF) sample were included in the study of isolates from 2002 to 2003. Seventy-one patients (74.7%) were confirmed as having Neisseria meningitidis either by culture (n = 40) or by porA PCR (n = 31) of their CSF. The overall case fatality rate (CFR) was 11.6%; the N. meningitidis-specific CFR was 4.2%. All 40 strains were fully susceptible to all antibiotics tested except sulfonamide, were serotyped as A:4/21:P1.20,9, and belonged to sequence type 7 (ST-7). The strains from 1988 to 1989 were also equally susceptible and were characterized as A:4/21:P1.20,9, but they belonged to ST-5. Antigenic characterization of the strains revealed differences in the repertoire of lipooligosaccharides and Opa proteins between the old and the recent strains. PCR analysis of the nine lgt genes revealed the presence of the lgtAHFG genes in both old and recent strains; lgtB was present in only some of the strains, but no correlation with sequence type was observed. Further analysis showed that in addition to their pgm alleles, the Ethiopian ST-5 and ST-7 strains also differed in their tbpB, opa, fetA, and lgtA genes. The occurrence of new antigenic structures in strains sharing the same serogroup, PorA, and PorB may help explain the replacement of ST-5 by ST-7 in the African meningitis belt.
Asunto(s)
Brotes de Enfermedades , Meningitis Meningocócica/epidemiología , Meningitis Meningocócica/microbiología , Neisseria meningitidis Serogrupo A/aislamiento & purificación , Adolescente , Adulto , Secuencia de Bases , Niño , Preescolar , ADN Bacteriano/genética , Brotes de Enfermedades/historia , Etiopía/epidemiología , Femenino , Genes Bacterianos , Genotipo , Historia del Siglo XX , Historia del Siglo XXI , Humanos , Lactante , Masculino , Meningitis Meningocócica/historia , Persona de Mediana Edad , Datos de Secuencia Molecular , Neisseria meningitidis Serogrupo A/clasificación , Neisseria meningitidis Serogrupo A/genética , Fenotipo , Serotipificación , Factores de TiempoRESUMEN
We developed two Neisseria meningitidis multiplex PCR assays to be used consecutively that allow determination of the serogroup and capsular status of serogroup A, B, C, 29E, W135, X, and Y cnl-3/cnl-1-like-containing N. meningitidis isolates by direct analysis of the amplicon size. These assays offer a rapid and simple method of serogrouping N. meningitidis.
Asunto(s)
Neisseria meningitidis/clasificación , Neisseria meningitidis/genética , Reacción en Cadena de la Polimerasa/métodos , Serotipificación/métodos , Secuencia de Bases , Portador Sano/microbiología , Cartilla de ADN/genética , ADN Bacteriano/genética , Humanos , Infecciones Meningocócicas/microbiología , Neisseria meningitidis/patogenicidad , Neisseria meningitidis Serogrupo A/clasificación , Neisseria meningitidis Serogrupo A/genética , Neisseria meningitidis Serogrupo A/patogenicidad , Neisseria meningitidis Serogrupo B/clasificación , Neisseria meningitidis Serogrupo B/genética , Neisseria meningitidis Serogrupo B/patogenicidad , Neisseria meningitidis Serogrupo C/clasificación , Neisseria meningitidis Serogrupo C/genética , Neisseria meningitidis Serogrupo C/patogenicidad , Neisseria meningitidis Serogrupo W-135/clasificación , Neisseria meningitidis Serogrupo W-135/genética , Neisseria meningitidis Serogrupo W-135/patogenicidad , Neisseria meningitidis Serogrupo Y/clasificación , Neisseria meningitidis Serogrupo Y/genética , Neisseria meningitidis Serogrupo Y/patogenicidad , Reacción en Cadena de la Polimerasa/estadística & datos numéricos , Sensibilidad y Especificidad , Serotipificación/estadística & datos numéricos , Virulencia/genéticaRESUMEN
It has been proposed that increased phase variation frequencies in Neisseria meningitidis augment transmissibility and invasiveness. A Himar1 mariner transposon mutant library was constructed in serogroup A N. meningitidis and screened for clones with increased phase variation frequencies. Insertions increasing the frequency of slippage events within mononucleotide repeat tracts were identified in three known phase variation-modulating genes (mutS, mutL, and uvrD), as well as six additional loci (pilP, fbpA, fbpB, NMA1233, and two intergenic regions). The implications of these insertion mutations are discussed.
Asunto(s)
Proteínas Bacterianas/genética , Regulación Bacteriana de la Expresión Génica , Mutagénesis Insercional , Neisseria meningitidis Serogrupo A/genética , Secuencias Repetitivas de Ácidos Nucleicos/genética , Proteínas Bacterianas/metabolismo , Mapeo Cromosómico , Cromosomas Bacterianos , Biblioteca de Genes , Humanos , Neisseria meningitidis Serogrupo A/clasificación , Especificidad de la Especie , TransposasasRESUMEN
Meningococcal serogroup-specific immunoglobulin G (IgG), IgG1, and IgG2 concentrations were assigned to three reference sera, CDC 1992, 89-SF, and 96/562, for meningococcal serogroups A, C, Y, and W135 via the method of cross standardization. The sum of the serogroup-specific IgG1 and IgG2 concentrations determined for the four meningococcal serogroups showed good agreement with the serogroup-specific IgG either determined here or as previously represented. Following the assignment of meningococcal serogroup-specific IgG1 and IgG2 concentration to these reference sera, a meningococcal serogroup-specific IgG1 and IgG2 enzyme-linked immunosorbent assay protocol was developed. The serogroup A and C specific subclass distribution of a panel of adult sera collected following vaccination with any combination of meningococcal serogroup C conjugate, bivalent, or tetravalent polysaccharide vaccines was determined. For the determination of serogroup W135 and Y specific subclass distribution, an adolescent panel 28 days following a single dose of either tetravalent polysaccharide or conjugate vaccine was used. The sum of the serogroup-specific IgG1 and IgG2 showed strong correlation with the serogroup-specific total IgG determined. The assignment here of IgG1 and IgG2 subclasses to these reference sera will allow more detailed evaluation of meningococcal conjugate and polysaccharide vaccines.
Asunto(s)
Anticuerpos Antibacterianos/sangre , Neisseria meningitidis/clasificación , Neisseria meningitidis/inmunología , Adolescente , Adulto , Ensayo de Inmunoadsorción Enzimática/normas , Humanos , Inmunoglobulina G/sangre , Infecciones Meningocócicas/inmunología , Infecciones Meningocócicas/microbiología , Infecciones Meningocócicas/prevención & control , Vacunas Meningococicas/inmunología , Neisseria meningitidis Serogrupo A/clasificación , Neisseria meningitidis Serogrupo A/inmunología , Neisseria meningitidis Serogrupo C/clasificación , Neisseria meningitidis Serogrupo C/inmunología , Neisseria meningitidis Serogrupo W-135/clasificación , Neisseria meningitidis Serogrupo W-135/inmunología , Neisseria meningitidis Serogrupo Y/clasificación , Neisseria meningitidis Serogrupo Y/inmunología , Estándares de Referencia , SerotipificaciónRESUMEN
In the African meningitis belt, the recurrent meningococcal meningitis epidemics are generally caused by serogroup A. In the past 20 years, other serogroups have been detected, such as X or W135, which have caused sporadic cases or clusters. We report here 134 meningitis cases caused by Neisseria meningitidis serogroup X that occurred in Niamey between 1995 and 2000. They represented 3.91% of the meningococcal isolates from all CSF samples, whereas 94.4% were of serogroup A. Meningococcal meningitis cases were detected using the framework of the routine surveillance system for reportable diseases organized by the Ministry of Public Health of Niger. The strains were isolated and determined by the reference laboratory for meningitis in Niamey (CERMES) and further typed at the WHO collaborating center of the Pharo in Marseille and at the National Reference Center for the Meningococci at the Institut Pasteur. Reference laboratories in Marseille and Paris characterized 47 isolates having the antigenic formula (serogroup:serotype:sero-subtype) X:NT:P1.5. Meningitis cases due to meningococcus serogroup X did not present any clinical or epidemiological differences to those due to serogroup A. The seasonal incidence was classical; 93.3% of the cases were recorded during the dry season. The mean age of patients was 9.2 years (+/- 6 years). The sex ratio M/F was 1.3. Case fatality rate was 11.9% without any difference related to age or sex. The increasing incidence of the serogroup X was not related to the decrease of serogroup A, but seemed cyclic, and evolved independently of the recurrence of both serogroups A and C.